Novel Nanotherapeutics for Cancer Immunotherapy by PD-L1-Aptamer-Functionalized and Fexofenadine-Loaded Albumin Nanoparticles

Immune checkpoint blockade (ICB) is an important strategy for cancer treatment and has achieved remarkable clinical results. Further enhancement of the efficacy of ICB therapy with a new technical approach is of potential medical importance. In this study, we constructed a novel nanotherapeutic agen...

Full description

Bibliographic Details

Published in:	Molecules
Main Authors:	Xialian Lai, Fengjiao Yao, Yacong An, Xundou Li, Xian-Da Yang
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Subjects:	PD-L1 aptamer albumin nanoparticles cancer immunotherapy immune checkpoint
Online Access:	https://www.mdpi.com/1420-3049/28/6/2556